This phase II trial compares the effect of GI-102 alone and in combination with pembrolizumab given before surgery in treating patients with IDH wildtype gliob…

Glioblastoma, IDH-WildtypeProgressive Astrocytoma, IDH-Mutant, Grade 4Progressive Glioblastoma+6 more

~Estimated

~$10 – $6,250

Mayo ClinicNCT07301268

Phase 1

A Phase Ib Open Label Clinical Trial to Evaluate the Safety and Efficacy of ERAS-801 in Recurrent Glioblastoma or Elderly Newly Diagnosed Glioblastoma Patients With EGFR Amplification and/or Mutation (ERAS-801-3.0)

This phase Ib trial tests the safety and side effects of ERAS-801 in treating patients with isocitrate dehydrogenase (IDH) wildtype, epidermal growth factor re…

GlioblastomaGlioblastoma, IDH-WildtypeGliosarcoma+3 more

~Estimated

~$10 – $6,250

Jonsson Comprehensive Cancer CenterNCT07089641

Observational

Exploration Into the Association Between Decorin (DCN) Expression and MR Phenotypes in GBM

This clinical trial uses a type of imaging scan called magnetic resonance imaging (MRI) to study brain tumor biology in patients with glioblastoma that can be …

GlioblastomaRecurrent GlioblastomaResectable Glioblastoma

~Estimated

~$10 – $6,250

Jonsson Comprehensive Cancer CenterNCT06090903